UK moves to address dire state of stroke care
This article was originally published in Clinica
There can be no stronger argument for a revolutionary investment in diagnostic imaging in the UK than is shown by the need for a radical improvement in the care of stroke - or do this specialism's needs lie elsewhere? The government, clinicians and pressure groups do not know the answer to this question and the ignorance is resulting in high levels of death and morbidity, which are not even recorded correctly due to widespread delay or failures in diagnosing stroke and transient ischaemic attack (TIA).
You may also be interested in...
Hours before the US FDA confirmed the first drug shortage due to active pharmaceutical ingredient constraints because of the coronavirus situation in China, generics industry leader Mylan came under pressure about the potential impact on its business.
Government advisory committee gives initial nod to what will become Japan’s most expensive single drug, but reimbursement pricing could come in for close scrutiny.
Laparoscopic power morcellation to remove uterine fibroids should only be performed with the use of a compatible containment system, and only on women younger than 50, the US FDA said in a newly published safety communication and draft guidance document. See what the president of the gynecologic trade group AAGL, Jubilee Brown, said about it here.